RA Capital — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Clinical-stage biopharmaceutical company committed to developing best-in-class novel therapy for hypertension treatment.
BiotechRadnor, US
Adam Levy(Executive Officer)Srinivas Akkaraju(Director)Alexander Asam(Director)
BoardBrian Taylor Slingsby(Director)Olivier Litzka(Director)
Board seatDerek DiRocco· per SEC Form D · $118M raise · filed Jun 2022
Empatica develops software and algorithms that monitor neurological patients through wearable sensors, providing real-time physiological and behavioral biomarkers to patients, clinicians, and researchers.
AI & Machine LearningDigital HealthHealthtechMedical DevicesCambridge, US
Rosalind Picard(Founder and Director of the Affective Computing Group at the MIT Media Lab and Faculty Chair, MIT Mind+Hand+Heart Wellbeing Initiative)Matteo Lai(Executive Officer, Director)Mario Scuderi(Director)Simone Tognetti(Director)
BiotechDallas, US
ANGELA SHEN(Director)HENRIK RASMUSSEN(Director)VINEET JINDAL(Executive Officer, Director)SUNJAY KAUSHAL(Director)WILLIAM NILAND(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.